939 related articles for article (PubMed ID: 24665829)
1. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
Dupont HL
Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
3. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
Fukudo S
Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
[TBL] [Abstract][Full Text] [Related]
4. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
Pimentel M
Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():37-49. PubMed ID: 26618924
[TBL] [Abstract][Full Text] [Related]
5. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
König J; Brummer RJ
Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
[TBL] [Abstract][Full Text] [Related]
7. Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets.
Dahlqvist G; Piessevaux H
Acta Gastroenterol Belg; 2011 Sep; 74(3):375-80. PubMed ID: 22103040
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
Hong SN; Rhee PL
World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
Lee KN; Lee OY
World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
[TBL] [Abstract][Full Text] [Related]
10. [Irritable Bowel Syndrome; gut microbiota and probiotic therapy].
Tojo González R; Suarez Gonzalez A; Rúas Madiedo P; Mancebo Mata A; Pipa Muñiz M; Barreiro Alonso E; Roman Llorente FJ; Moro Villar MC; Arce González MM; Villegas Diaz MF; Mosquera Sierra E; Ruiz Ruiz M
Nutr Hosp; 2015 Feb; 31 Suppl 1():83-8. PubMed ID: 25659060
[TBL] [Abstract][Full Text] [Related]
11. The Intestinal Microbiota and Irritable Bowel Syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
[TBL] [Abstract][Full Text] [Related]
12. Irritable bowel syndrome: a gut microbiota-related disorder?
Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
[TBL] [Abstract][Full Text] [Related]
13. Probiotics and irritable bowel syndrome.
Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
[TBL] [Abstract][Full Text] [Related]
14. Microbiome, antibiotics and irritable bowel syndrome.
Ahmad OF; Akbar A
Br Med Bull; 2016 Dec; 120(1):91-99. PubMed ID: 27737852
[TBL] [Abstract][Full Text] [Related]
15. Targeting the gut microbiota for the treatment of irritable bowel syndrome.
Herndon CC; Wang YP; Lu CL
Kaohsiung J Med Sci; 2020 Mar; 36(3):160-170. PubMed ID: 31782606
[TBL] [Abstract][Full Text] [Related]
16. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiome and irritable bowel syndrome: State of art review.
Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
[TBL] [Abstract][Full Text] [Related]
18. [Microbiota and irritable bowel syndrome].
Ducrotté P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S52-6. PubMed ID: 20889005
[TBL] [Abstract][Full Text] [Related]
19. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V
World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.
Hyland NP; Quigley EM; Brint E
World J Gastroenterol; 2014 Jul; 20(27):8859-66. PubMed ID: 25083059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]